Abstract
The multiple sclerosis (MS) bladder is associated with an increased risk of neurogenic problems that are distressing for people with MS (PwMS), as well as being a leading cause of hospital admissions. Almost all PwMS will have bladder symptoms after 10 years of living with the disease, which impacts their quality of life and has a huge economic burden on the NHS for problems including urinary tract infections (UTIs). Following the publication of updated MS bladder management guidelines and the development of MS bladder pathways, Sue Thomas outlines the implementation progress that has been made within the past year.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
